Importance of LGBTQ+-Inclusive Language When Developing and Selecting Patient-Reported Outcome Measures
JAMA Dermatol
.
2024 Dec 4.
doi: 10.1001/jamadermatol.2024.5073.
Online ahead of print.
Authors
John S Barbieri
1
2
,
Mya L Roberson
3
4
Affiliations
1
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
2
Associate Editor, JAMA Dermatology.
3
Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill.
4
Associate Editor for Diversity, Equity, and Inclusion, JAMA Dermatology.
PMID:
39630474
DOI:
10.1001/jamadermatol.2024.5073
No abstract available